Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Patients with Alzheimer’s disease have increased cellular amyloid uptake

View ORCID ProfileDmitry V. Zaretsky, Maria V. Zaretskaia, Yaroslav I. Molkov, for the Alzheimer’s Disease Neuroimaging Initiative
doi: https://doi.org/10.1101/2022.01.12.22269196
Dmitry V. Zaretsky
1Zarbio, Chapel Hill, NC 27516
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Dmitry V. Zaretsky
  • For correspondence: dmitry.zaretsky@zar.bio
Maria V. Zaretskaia
1Zarbio, Chapel Hill, NC 27516
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yaroslav I. Molkov
2Department of Mathematics and Statistics and Neuroscience Institute, Georgia State University, Atlanta, GA 30303
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Amyloid plaques are the main signature of Alzheimer’s disease (AD). Beta-amyloid (Aβ) concentration in cerebrospinal fluid (CSF-Aβ) and the density of amyloid depositions have a strong negative correlation. However, AD patients have lower CSF-Aβ levels compared to cognitively normal people even after accounting for this correlation. The goal of this study was to infer variations of parameters in Aβ metabolism of AD patients that underlie this difference using data from the Alzheimer’s Disease Neuroimaging Initiative cohort.

We found that AD patients had dramatically increased rates of cellular amyloid uptake compared to individuals with normal cognition (NC). A group with late-onset mild cognitive impairment (LMCI) also exhibited stronger amyloid uptake, however this was less pronounced than in the AD group. Estimated parameters in the early-onset MCI group did not differ significantly from those in the NC group.

Aβ cytotoxicity depends on both the amount of peptide internalized by cells and its intracellular degradation into toxic products. Based on our results, we speculate that AD and LMCI are associated with increased cellular amyloid uptake which leads to faster disease progression, whereas the early-onset MCI may be mediated by the increased production of toxic amyloid metabolites.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

http://adni.loni.usc.edu/about/

Funding Statement

This study did not receive any funding

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study involves only openly available human data, which can be obtained from ADNI.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • ↵# Data used in the preparation of this article were obtained from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. A complete listing of ADNI investigators can be found at: http://adni.loni.usc.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf

Data Availability

All data produced in the present study are available upon reasonable request to the authors

http://adni.loni.usc.edu/about/

  • Abbreviations

    AD
    Alzheimer’s disease
    MCI
    mild cognitive impairment
    LMCI
    late-onset MCI
    EMCI
    earlyonset MCI
    NC
    normal cognition
    Aβ
    beta-amyloid
    Aβ42
    Aβ1-42
    CSF
    cerebrospinal fluid
    CSF-Aβ42
    concentration of Aβ42 in the CSF
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
    Back to top
    PreviousNext
    Posted January 13, 2022.
    Download PDF
    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Patients with Alzheimer’s disease have increased cellular amyloid uptake
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Patients with Alzheimer’s disease have increased cellular amyloid uptake
    Dmitry V. Zaretsky, Maria V. Zaretskaia, Yaroslav I. Molkov, for the Alzheimer’s Disease Neuroimaging Initiative
    medRxiv 2022.01.12.22269196; doi: https://doi.org/10.1101/2022.01.12.22269196
    Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
    Citation Tools
    Patients with Alzheimer’s disease have increased cellular amyloid uptake
    Dmitry V. Zaretsky, Maria V. Zaretskaia, Yaroslav I. Molkov, for the Alzheimer’s Disease Neuroimaging Initiative
    medRxiv 2022.01.12.22269196; doi: https://doi.org/10.1101/2022.01.12.22269196

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Neurology
    Subject Areas
    All Articles
    • Addiction Medicine (162)
    • Allergy and Immunology (416)
    • Anesthesia (91)
    • Cardiovascular Medicine (863)
    • Dentistry and Oral Medicine (159)
    • Dermatology (98)
    • Emergency Medicine (251)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (394)
    • Epidemiology (8573)
    • Forensic Medicine (4)
    • Gastroenterology (388)
    • Genetic and Genomic Medicine (1759)
    • Geriatric Medicine (167)
    • Health Economics (373)
    • Health Informatics (1250)
    • Health Policy (622)
    • Health Systems and Quality Improvement (469)
    • Hematology (196)
    • HIV/AIDS (378)
    • Infectious Diseases (except HIV/AIDS) (10319)
    • Intensive Care and Critical Care Medicine (553)
    • Medical Education (192)
    • Medical Ethics (51)
    • Nephrology (213)
    • Neurology (1682)
    • Nursing (97)
    • Nutrition (252)
    • Obstetrics and Gynecology (328)
    • Occupational and Environmental Health (451)
    • Oncology (930)
    • Ophthalmology (264)
    • Orthopedics (102)
    • Otolaryngology (172)
    • Pain Medicine (114)
    • Palliative Medicine (40)
    • Pathology (254)
    • Pediatrics (538)
    • Pharmacology and Therapeutics (254)
    • Primary Care Research (209)
    • Psychiatry and Clinical Psychology (1775)
    • Public and Global Health (3854)
    • Radiology and Imaging (626)
    • Rehabilitation Medicine and Physical Therapy (320)
    • Respiratory Medicine (521)
    • Rheumatology (208)
    • Sexual and Reproductive Health (168)
    • Sports Medicine (158)
    • Surgery (191)
    • Toxicology (36)
    • Transplantation (101)
    • Urology (76)